Patent · US Active

Use of VEGF inhibitors for treatment of eye disorders

US7521049B2 · kind B2 · utility

67Cited by
2References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2007
Grant dateApr 21, 2009
Priority date—
Expiry dateNov 30, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified chimeric polypeptides with improved pharmacokinetics and improved tissue penetration are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.